Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immunogenicity and Safety of Sinovac Varicella Vaccine in Healthy Children
NCT06314724Phase 3Completed
- Sponsor
- Sinovac Biotech Ltd.
- Start
- Feb 2024
- Primary completion
- Sep 2024
- Countries
- 1
01
Overview
A Phase 3 trial of varicella virus vaccine live in varicella (VZV), sponsored by Sinovac Biotech Ltd.. Started Feb 2024; status: completed.
02
Drugs
varicella virus vaccine live
03
Conditions
varicella (VZV)
Beyond the preview
Go deeper on NCT06314724.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06314724.